Use of Checkpoint Inhibitors in Unresectable HCC

Use of Checkpoint Inhibitors in Unresectable HCC

obr

3 years
629 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Nevena Damjanov, MD of University of Pennsylvania talks about how checkpoint inhibitors will be incorporated into unresectable HCC treatment at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Up Next Autoplay